Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial
Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of Hb...
Gespeichert in:
Veröffentlicht in: | Primary care diabetes 2024-12, Vol.18 (6), p.624-631 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 631 |
---|---|
container_issue | 6 |
container_start_page | 624 |
container_title | Primary care diabetes |
container_volume | 18 |
creator | Castaño, Ramón A. Granados, Maria A. Trujillo, Natalia Bernal, Juan P. Trujillo, Juan F. Trasmondi, Patrizia Maestre, Angel F. Cardona, Juan S. Gonzalez, Rossmary Larrarte, María A. Hernandez, Derly C. Barengo, Noël C. Reynales, Humberto |
description | Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of HbA1c immediately after a screening questionnaire will increase the proportion of individuals showing up for a lab-based confirmatory test as Point-of-care (POC) provides immediate availability, which is expected to reduce loss-to-follow-up.
This trial was a two-arm, randomized controlled, open-label study. Participants were recruited using the FINDRISC Score in a primary care and community setting. All 902 eligible participants were randomized into the intervention (n=511) and control (n=391) group. The intervention group was given information on healthy lifestyles, and a Point-of-care POC-HbA1c test was performed during the same visit. The control group was only given information on healthy lifestyles. Participants in both groups received a written prescription to have an oral glucose tolerance test (OGTT) performed within the next 30 days. Follow-up phone calls were made at 30 and 90 days to check if participant had undergone the test. The total duration of the intervention was 8 months. The posterior data analysis was made by using the Kolmogorov-Smirnoff test for the quantitative variables, and the descriptive statistics were expressed as means and standard deviation, or median and interquartile range 25 %-75 %, as appropriate.
At 30 days, 28 % of participants in the intervention group and 26.1 % in the control group undertook the OGTT (RD 1.90 %; 95 % CI −3.94; 7.73). At 90 days, 35.8 % of participants in the intervention group and 37.1 % in the control group undertook the OGTT. There was no statistically significant difference (RD – 3.17 %; 95 % CI −7.04; 0.70) between both groups.
The data suggest that performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT.
•This study aimed at adding scientific evidence about how to improve early detection of type 2 diabetes.•We tried to answer whether applying a screening questionnaire followed by a POC-HbA1c test to those identified as at risk of diabetes increases the number of patients who undergo a confirmatory test.•Performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT |
doi_str_mv | 10.1016/j.pcd.2024.09.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3108763843</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1751991824001888</els_id><sourcerecordid>3108763843</sourcerecordid><originalsourceid>FETCH-LOGICAL-c235t-e8f4563b9b7247f3052257f77eb3e5dd99e6bf833940c9f49d81828343c22ecd3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEohd4ADbISzYJviRjWyzQaIAWqdKwGNaWYx9TTxN7sJ1K5VV4WTydwpKVj6X_-6VzvqZ5Q3BHMFm933cHYzuKad9h2WE8PGvOieCixZTg53XmA2mlJOKsuch5j_GKMMFfNmdMMsJ6zM-b358iZHSA5GKaffiBNPoWfSjt1rUbnQBdj2tiUIFckA8mgc6Ayi0gc6uDqWh0aAkWUtF3j3hA26vdDuk51p8P1t97u-gpI11Q8vnuCFivR6iVH9EaJR1snP0vsMjEUFKcpjqW5PX0qnnhKgmvn97L5vuXz7vNdXuzvfq6Wd-0hrKhtCBcP6zYKEdOe-4YHigduOMcRgaDtVLCanSCMdljI10vrSCCCtYzQykYyy6bd6feQ4o_l7qpmn02ME06QFyyYgQLvmKiZzVKTlGTYs4JnDokP-v0oAhWRydqr6oTdXSisFTVSWXePtUv4wz2H_FXQg18OAWgLnnvIalsPNTrWp_AFGWj_0_9H9sonS0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3108763843</pqid></control><display><type>article</type><title>Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Castaño, Ramón A. ; Granados, Maria A. ; Trujillo, Natalia ; Bernal, Juan P. ; Trujillo, Juan F. ; Trasmondi, Patrizia ; Maestre, Angel F. ; Cardona, Juan S. ; Gonzalez, Rossmary ; Larrarte, María A. ; Hernandez, Derly C. ; Barengo, Noël C. ; Reynales, Humberto</creator><creatorcontrib>Castaño, Ramón A. ; Granados, Maria A. ; Trujillo, Natalia ; Bernal, Juan P. ; Trujillo, Juan F. ; Trasmondi, Patrizia ; Maestre, Angel F. ; Cardona, Juan S. ; Gonzalez, Rossmary ; Larrarte, María A. ; Hernandez, Derly C. ; Barengo, Noël C. ; Reynales, Humberto</creatorcontrib><description>Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of HbA1c immediately after a screening questionnaire will increase the proportion of individuals showing up for a lab-based confirmatory test as Point-of-care (POC) provides immediate availability, which is expected to reduce loss-to-follow-up.
This trial was a two-arm, randomized controlled, open-label study. Participants were recruited using the FINDRISC Score in a primary care and community setting. All 902 eligible participants were randomized into the intervention (n=511) and control (n=391) group. The intervention group was given information on healthy lifestyles, and a Point-of-care POC-HbA1c test was performed during the same visit. The control group was only given information on healthy lifestyles. Participants in both groups received a written prescription to have an oral glucose tolerance test (OGTT) performed within the next 30 days. Follow-up phone calls were made at 30 and 90 days to check if participant had undergone the test. The total duration of the intervention was 8 months. The posterior data analysis was made by using the Kolmogorov-Smirnoff test for the quantitative variables, and the descriptive statistics were expressed as means and standard deviation, or median and interquartile range 25 %-75 %, as appropriate.
At 30 days, 28 % of participants in the intervention group and 26.1 % in the control group undertook the OGTT (RD 1.90 %; 95 % CI −3.94; 7.73). At 90 days, 35.8 % of participants in the intervention group and 37.1 % in the control group undertook the OGTT. There was no statistically significant difference (RD – 3.17 %; 95 % CI −7.04; 0.70) between both groups.
The data suggest that performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT.
•This study aimed at adding scientific evidence about how to improve early detection of type 2 diabetes.•We tried to answer whether applying a screening questionnaire followed by a POC-HbA1c test to those identified as at risk of diabetes increases the number of patients who undergo a confirmatory test.•Performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT</description><identifier>ISSN: 1751-9918</identifier><identifier>ISSN: 1878-0210</identifier><identifier>EISSN: 1878-0210</identifier><identifier>DOI: 10.1016/j.pcd.2024.09.005</identifier><identifier>PMID: 39313407</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Biomarkers - blood ; Blood Glucose - metabolism ; Diabetes ; Diabetes Mellitus ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - diagnosis ; Early Diagnosis ; Female ; Glucose Tolerance Test ; Glycated Hemoglobin - metabolism ; Glycosylated Hemoglobin Measurement ; HbAIc ; Healthy Lifestyle ; Humans ; Male ; Middle Aged ; Patient Education as Topic ; Point-of-Care Systems ; Point-of-Care Testing ; Predictive Value of Tests ; Risk Assessment ; Risk Factors ; Surveys and Questionnaires ; Time Factors</subject><ispartof>Primary care diabetes, 2024-12, Vol.18 (6), p.624-631</ispartof><rights>2024 Primary Care Diabetes Europe</rights><rights>Copyright © 2024 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c235t-e8f4563b9b7247f3052257f77eb3e5dd99e6bf833940c9f49d81828343c22ecd3</cites><orcidid>0000-0003-0660-3091</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1751991824001888$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39313407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castaño, Ramón A.</creatorcontrib><creatorcontrib>Granados, Maria A.</creatorcontrib><creatorcontrib>Trujillo, Natalia</creatorcontrib><creatorcontrib>Bernal, Juan P.</creatorcontrib><creatorcontrib>Trujillo, Juan F.</creatorcontrib><creatorcontrib>Trasmondi, Patrizia</creatorcontrib><creatorcontrib>Maestre, Angel F.</creatorcontrib><creatorcontrib>Cardona, Juan S.</creatorcontrib><creatorcontrib>Gonzalez, Rossmary</creatorcontrib><creatorcontrib>Larrarte, María A.</creatorcontrib><creatorcontrib>Hernandez, Derly C.</creatorcontrib><creatorcontrib>Barengo, Noël C.</creatorcontrib><creatorcontrib>Reynales, Humberto</creatorcontrib><title>Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial</title><title>Primary care diabetes</title><addtitle>Prim Care Diabetes</addtitle><description>Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of HbA1c immediately after a screening questionnaire will increase the proportion of individuals showing up for a lab-based confirmatory test as Point-of-care (POC) provides immediate availability, which is expected to reduce loss-to-follow-up.
This trial was a two-arm, randomized controlled, open-label study. Participants were recruited using the FINDRISC Score in a primary care and community setting. All 902 eligible participants were randomized into the intervention (n=511) and control (n=391) group. The intervention group was given information on healthy lifestyles, and a Point-of-care POC-HbA1c test was performed during the same visit. The control group was only given information on healthy lifestyles. Participants in both groups received a written prescription to have an oral glucose tolerance test (OGTT) performed within the next 30 days. Follow-up phone calls were made at 30 and 90 days to check if participant had undergone the test. The total duration of the intervention was 8 months. The posterior data analysis was made by using the Kolmogorov-Smirnoff test for the quantitative variables, and the descriptive statistics were expressed as means and standard deviation, or median and interquartile range 25 %-75 %, as appropriate.
At 30 days, 28 % of participants in the intervention group and 26.1 % in the control group undertook the OGTT (RD 1.90 %; 95 % CI −3.94; 7.73). At 90 days, 35.8 % of participants in the intervention group and 37.1 % in the control group undertook the OGTT. There was no statistically significant difference (RD – 3.17 %; 95 % CI −7.04; 0.70) between both groups.
The data suggest that performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT.
•This study aimed at adding scientific evidence about how to improve early detection of type 2 diabetes.•We tried to answer whether applying a screening questionnaire followed by a POC-HbA1c test to those identified as at risk of diabetes increases the number of patients who undergo a confirmatory test.•Performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Blood Glucose - metabolism</subject><subject>Diabetes</subject><subject>Diabetes Mellitus</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Early Diagnosis</subject><subject>Female</subject><subject>Glucose Tolerance Test</subject><subject>Glycated Hemoglobin - metabolism</subject><subject>Glycosylated Hemoglobin Measurement</subject><subject>HbAIc</subject><subject>Healthy Lifestyle</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Education as Topic</subject><subject>Point-of-Care Systems</subject><subject>Point-of-Care Testing</subject><subject>Predictive Value of Tests</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Surveys and Questionnaires</subject><subject>Time Factors</subject><issn>1751-9918</issn><issn>1878-0210</issn><issn>1878-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu1DAUhiMEohd4ADbISzYJviRjWyzQaIAWqdKwGNaWYx9TTxN7sJ1K5VV4WTydwpKVj6X_-6VzvqZ5Q3BHMFm933cHYzuKad9h2WE8PGvOieCixZTg53XmA2mlJOKsuch5j_GKMMFfNmdMMsJ6zM-b358iZHSA5GKaffiBNPoWfSjt1rUbnQBdj2tiUIFckA8mgc6Ayi0gc6uDqWh0aAkWUtF3j3hA26vdDuk51p8P1t97u-gpI11Q8vnuCFivR6iVH9EaJR1snP0vsMjEUFKcpjqW5PX0qnnhKgmvn97L5vuXz7vNdXuzvfq6Wd-0hrKhtCBcP6zYKEdOe-4YHigduOMcRgaDtVLCanSCMdljI10vrSCCCtYzQykYyy6bd6feQ4o_l7qpmn02ME06QFyyYgQLvmKiZzVKTlGTYs4JnDokP-v0oAhWRydqr6oTdXSisFTVSWXePtUv4wz2H_FXQg18OAWgLnnvIalsPNTrWp_AFGWj_0_9H9sonS0</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Castaño, Ramón A.</creator><creator>Granados, Maria A.</creator><creator>Trujillo, Natalia</creator><creator>Bernal, Juan P.</creator><creator>Trujillo, Juan F.</creator><creator>Trasmondi, Patrizia</creator><creator>Maestre, Angel F.</creator><creator>Cardona, Juan S.</creator><creator>Gonzalez, Rossmary</creator><creator>Larrarte, María A.</creator><creator>Hernandez, Derly C.</creator><creator>Barengo, Noël C.</creator><creator>Reynales, Humberto</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0660-3091</orcidid></search><sort><creationdate>202412</creationdate><title>Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial</title><author>Castaño, Ramón A. ; Granados, Maria A. ; Trujillo, Natalia ; Bernal, Juan P. ; Trujillo, Juan F. ; Trasmondi, Patrizia ; Maestre, Angel F. ; Cardona, Juan S. ; Gonzalez, Rossmary ; Larrarte, María A. ; Hernandez, Derly C. ; Barengo, Noël C. ; Reynales, Humberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c235t-e8f4563b9b7247f3052257f77eb3e5dd99e6bf833940c9f49d81828343c22ecd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Blood Glucose - metabolism</topic><topic>Diabetes</topic><topic>Diabetes Mellitus</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Early Diagnosis</topic><topic>Female</topic><topic>Glucose Tolerance Test</topic><topic>Glycated Hemoglobin - metabolism</topic><topic>Glycosylated Hemoglobin Measurement</topic><topic>HbAIc</topic><topic>Healthy Lifestyle</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Education as Topic</topic><topic>Point-of-Care Systems</topic><topic>Point-of-Care Testing</topic><topic>Predictive Value of Tests</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Surveys and Questionnaires</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castaño, Ramón A.</creatorcontrib><creatorcontrib>Granados, Maria A.</creatorcontrib><creatorcontrib>Trujillo, Natalia</creatorcontrib><creatorcontrib>Bernal, Juan P.</creatorcontrib><creatorcontrib>Trujillo, Juan F.</creatorcontrib><creatorcontrib>Trasmondi, Patrizia</creatorcontrib><creatorcontrib>Maestre, Angel F.</creatorcontrib><creatorcontrib>Cardona, Juan S.</creatorcontrib><creatorcontrib>Gonzalez, Rossmary</creatorcontrib><creatorcontrib>Larrarte, María A.</creatorcontrib><creatorcontrib>Hernandez, Derly C.</creatorcontrib><creatorcontrib>Barengo, Noël C.</creatorcontrib><creatorcontrib>Reynales, Humberto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Primary care diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castaño, Ramón A.</au><au>Granados, Maria A.</au><au>Trujillo, Natalia</au><au>Bernal, Juan P.</au><au>Trujillo, Juan F.</au><au>Trasmondi, Patrizia</au><au>Maestre, Angel F.</au><au>Cardona, Juan S.</au><au>Gonzalez, Rossmary</au><au>Larrarte, María A.</au><au>Hernandez, Derly C.</au><au>Barengo, Noël C.</au><au>Reynales, Humberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial</atitle><jtitle>Primary care diabetes</jtitle><addtitle>Prim Care Diabetes</addtitle><date>2024-12</date><risdate>2024</risdate><volume>18</volume><issue>6</issue><spage>624</spage><epage>631</epage><pages>624-631</pages><issn>1751-9918</issn><issn>1878-0210</issn><eissn>1878-0210</eissn><abstract>Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of HbA1c immediately after a screening questionnaire will increase the proportion of individuals showing up for a lab-based confirmatory test as Point-of-care (POC) provides immediate availability, which is expected to reduce loss-to-follow-up.
This trial was a two-arm, randomized controlled, open-label study. Participants were recruited using the FINDRISC Score in a primary care and community setting. All 902 eligible participants were randomized into the intervention (n=511) and control (n=391) group. The intervention group was given information on healthy lifestyles, and a Point-of-care POC-HbA1c test was performed during the same visit. The control group was only given information on healthy lifestyles. Participants in both groups received a written prescription to have an oral glucose tolerance test (OGTT) performed within the next 30 days. Follow-up phone calls were made at 30 and 90 days to check if participant had undergone the test. The total duration of the intervention was 8 months. The posterior data analysis was made by using the Kolmogorov-Smirnoff test for the quantitative variables, and the descriptive statistics were expressed as means and standard deviation, or median and interquartile range 25 %-75 %, as appropriate.
At 30 days, 28 % of participants in the intervention group and 26.1 % in the control group undertook the OGTT (RD 1.90 %; 95 % CI −3.94; 7.73). At 90 days, 35.8 % of participants in the intervention group and 37.1 % in the control group undertook the OGTT. There was no statistically significant difference (RD – 3.17 %; 95 % CI −7.04; 0.70) between both groups.
The data suggest that performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT.
•This study aimed at adding scientific evidence about how to improve early detection of type 2 diabetes.•We tried to answer whether applying a screening questionnaire followed by a POC-HbA1c test to those identified as at risk of diabetes increases the number of patients who undergo a confirmatory test.•Performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39313407</pmid><doi>10.1016/j.pcd.2024.09.005</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0660-3091</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1751-9918 |
ispartof | Primary care diabetes, 2024-12, Vol.18 (6), p.624-631 |
issn | 1751-9918 1878-0210 1878-0210 |
language | eng |
recordid | cdi_proquest_miscellaneous_3108763843 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Aged Biomarkers - blood Blood Glucose - metabolism Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - diagnosis Early Diagnosis Female Glucose Tolerance Test Glycated Hemoglobin - metabolism Glycosylated Hemoglobin Measurement HbAIc Healthy Lifestyle Humans Male Middle Aged Patient Education as Topic Point-of-Care Systems Point-of-Care Testing Predictive Value of Tests Risk Assessment Risk Factors Surveys and Questionnaires Time Factors |
title | Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A47%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20performing%20a%20Point-Of-Care%20HbA1c%20test%20increase%20the%20chances%20of%20undertaking%20an%20OGTT%20among%20individuals%20at%20risk%20of%20diabetes?%20A%20randomized%20controlled%20trial&rft.jtitle=Primary%20care%20diabetes&rft.au=Casta%C3%B1o,%20Ram%C3%B3n%20A.&rft.date=2024-12&rft.volume=18&rft.issue=6&rft.spage=624&rft.epage=631&rft.pages=624-631&rft.issn=1751-9918&rft.eissn=1878-0210&rft_id=info:doi/10.1016/j.pcd.2024.09.005&rft_dat=%3Cproquest_cross%3E3108763843%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3108763843&rft_id=info:pmid/39313407&rft_els_id=S1751991824001888&rfr_iscdi=true |